XACT Robotics Announces Latest Financing Round Totaling $36M

Healionics Raises $4.7M Equity Round to Support Commercialization of STARgraft Vascular Graft

Healionics is preparing to commercialize its innovative STARgraft vascular graft, designed to provide a safer and more reliable means to access the bloodstream for dialysis in patients with kidney failure.

St. Elizabeth Healthcare Enhances Access To Cardiac Care With Multi-specialty Outpatient Building

"We opened the Heart & Vascular Institute six years ago with the goal of improving access to quality cardiovascular care for individuals in our region, and since then, we've made impressive strides in service offerings and patient outcomes," said D.P. Suresh, MD, Cardiologist and Executive Medical Director of the St. Elizabeth HVI.

Burgeoning Demand for MRI-guided Radiation Therapy Systems Market to Fuel Market Growth Thorough the COVID-19 Crisis Period

The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR.

November 13, 2019

XACT Robotics Ltd. today announced the successful completion of its latest financing round totaling $36 million. The company intends to use the proceeds to support the commercialization and continued development activities in support of the recent U.S. market cleared XACT Robotic System, which also has CE Mark. The XACT Robotic System is the first hands-free robotic system combining image-based planning and navigation with insertion and steering of various instruments to the desired target across an array of clinical applications and indications.

“As we continue to build momentum for our robotic system, we will use the recent funding to launch the system to select U.S. radiology Centers of Excellence partners,” said Chen Levin, CEO, XACT Robotics. “In addition, we will invest to continue expanding the utilization of the system and support our future launch cycle, including compatibility of the XACT Robotic System with additional imaging modalities and clinical applications to address a broad range of patient care needs.”

The current financing round included leading investors in the surgical robotics space, such as Chasing Value Asset Management Inc. (CA, USA) who previously held positions in MAKO Surgical Corp. (acquired by Stryker Corp. in 2013), Mazor Robotics (acquired by Medtronic in 2018), and most recently Corindus Vascular Robotics (acquired by Siemens in 2019). They join the current shareholders of the company including Shizim Group and MEDX Ventures Group.

XACT Robotics was founded by Harel Gadot, a renowned entrepreneur in the MedTech robotics space. The technology is based on research originally conducted at the Technion – Israel Institute of Technology, by Prof. Moshe Shoham, founder of Mazor Robotics (acquired by Medtronic in 2018).

The Company announced they will debut its technology at the 2019 Radiological Society of North America conference (RSNA) to be held in Chicago, IL on December 1 – 6, 2019 (exhibit booth #1650).

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles